As previously mentioned, IGF2BP2 can disrupt miRNA-dependent mRNA decay by binding to miRNA target sites, thereby weakening the interaction between miRNAs and Ago2 or acting as cytoplasmic “safe houses” to protect mRNAs in the cancer context [78,79]. Here, IGF2BP2 is linked to cancer.